Teva Pharmaceutical Industries Limited (TEVA.TA)
Makes generic drugs and specialty medicines for conditions like cancer, multiple sclerosis, and migraine.
10,180.00+0.06%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+81.9%
The outlook
Teva trades at 10180, sitting well above both its 50- and 200-day moving averages and positioned near the upper end of its 52-week range. Analyst coverage shows a bullish lean with a score of 84/100. The stock carries a trailing P/E of 25.0, reflecting current valuation relative to earnings.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range81% of the way from its 52-week low to high
Market cap
$118.54B
52-wk high
11,350.00
52-wk low
5,305.00
50-day avg
9,873.80
200-day avg
9,527.53
Trailing P/E
25.0